Therapeutic application of extracellular vesicles for various kidney diseases: a brief review

키워드

참고문헌 (53)

1. Karpman D, "Extracellular vesicles in renal disease", Nat Rev Nephrol, 13, pp.545~562 (2017)
2. Joshua H. Lipschutz, "The role of the exocyst in renal ciliogenesis, cystogenesis, tubulogenesis, and development", Kidney Research and Clinical Practice, 38(3), pp.260~266 (2019), 대한신장학회[DOI]
3. 이설아, "Extracellular vesicles in kidneys and their clinical potential in renal diseases", Kidney Research and Clinical Practice, 40(2), pp.194~207 (2021), 대한신장학회[DOI]
4. Linxweiler J, "Extracellular vesicles in urological malignancies : an update", Nat Rev Urol, 17, pp.11~27 (2020)
5. Jing H, "The role of extracellular vesicles in renal fibrosis", Cell Death Dis, 10, pp.367~ (2019)
6. Behrens F, "Extracellular vesicles as regulators of kidney function and disease", Intensive Care Med Exp, 8, pp.22~ (2020)
7. Xu M, "Recent advancements in the loading and modification of therapeutic exosomes", Front Bioeng Biotechnol, 8, pp.586130~ (2020)
8. Bochon B, "Mesenchymal stem cells-potential applications in kidney diseases", Int J Mol Sci, 20, pp.2462~ (2019)
9. Chen W, "Microvesicles derived from human Wharton’s Jelly mesenchymal stem cells ameliorate ischemia-reperfusion-induced renal fibrosis by releasing from G2", M cell cycle arrest, 2017, pp.474, 4207~4218
10. Zhang G, "The anti-oxidative role of micro-vesicles derived from human Wharton-Jelly mesenchymal stromal cells through NOX2", gp91(phox)suppression in alleviating renal ischemia-reperfusion injury in rats, 2014, pp.9, e92129~
11. Li X, "Human urine-derived stem cells protect against renal ischemia", reperfusion injury in a rat model via exosomal miR-146a-5p which targets IRAK1, 2020, pp.10, 9561~9578
12. Zhu G, "Exosomes from humanbone-marrow-derived mesenchymal stem cells protect against renal ischemia", reperfusion injury via transferring miR-199a3p, 2019, pp.234, 23736~23749
13. Pan T, "Delayed remote ischemic preconditioning confers renoprotection against septic acute kidney injury via exosomal miR-21", Theranostics, 9, pp.405~423 (2019)
14. Grange C, "Urinary extracellular vesicles carrying Klotho improve the recovery of renal function in an acute tubular injury model", Mol Ther, 28, pp.490~502 (2020)
15. Christov M, "Fibroblast growth factor 23 and Klotho in AKI", Semin Nephrol, 39, pp.57~75 (2019)
16. Dominguez JM 2nd, "Human extracellular microvesicles from renal tubules reverse kidney ischemia-reperfusion injury in rats", PLoS One, 13, pp.e0202550~ (2018)
17. Brigstock DR, "Extracellular vesicles in organ fibrosis : mechanisms, therapies, and diagnostics", Cells, 10, pp.1596~ (2021)
18. Ebrahim N, "Mesenchymal stem cell-derived exosomes ameliorated diabetic nephropathy by autophagy induction through the mTOR signaling pathway", Cells, 7, pp.226~ (2018)
19. Nagaishi K, "Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes", Sci Rep, 6, pp.34842~ (2016)
20. Lindoso RS, "Adipose mesenchymal cells-derived EVs alleviate DOCA-salt-induced hypertension by promoting cardio-renal protection", Mol Ther Methods Clin Dev, 16, pp.63~77 (2020)
21. Cambier L, "Angiotensin II-induced end-organ damage in mice is attenuated by human exosomes and by an exosomal Y RNA fragment", Hypertension, 72, pp.370~380 (2018)
22. Cantaluppi V, "Endothelial progenitor cell-derived extracellular vesicles protect from complement-mediated mesangial injury in experimental anti-Thy1. 1 glomerulonephritis", Nephrol Dial Transplant, 30, pp.410~422 (2015)
23. Eirin A, "Mesenchymal stem cell-derived extracellular vesicles attenuate kidney inflammation", Kidney Int, 92, pp.114~124 (2017)
24. Song T, "Mesenchymal stem cell-derived extracellular vesicles induce regulatory t cells to ameliorate chronic kidney injury", Hypertension, 75, pp.1223~1232 (2020)
25. Quaglia M, "Extracellular vesicles as mediators of cellular crosstalk between immune system and kidney graft", Front Immunol, 11, pp.74~ (2020)
26. Yu X, "CD4+CD25+ regulatory T cells-derived exosomes prolonged kidney allograft survival in a rat model", Cell Immunol, 285, pp.62~68 (2013)
27. Pang XL, "Immature dendritic cells derived exosomes promotes immune tolerance by regulating T cell differentiation in renal transplantation", Aging(Albany NY), 11, pp.8911~8924 (2019)
28. Wu X, "Micro-vesicles derived from human Wharton’s Jelly mesenchymal stromal cells mitigate renal ischemia-reperfusion injury in rats after cardiac death renal transplantation", J Cell Biochem, 119, pp.1879~1888 (2018)
29. Nomura S, "Probucol and ticlopidine : effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetes", Atherosclerosis, 174, pp.329~335 (2004)
30. Nomura S, "The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients", Platelets, 20, pp.16~22 (2009)
31. Dasgupta SK, "Developmental endothelial locus-1(Del-1)mediates clearance of platelet microparticles by the endothelium", Circulation, 125, pp.1664~1672 (2012)
32. Mossberg M, "C1-inhibitor decreases the release of vasculitis-like chemotactic endothelial microvesicles", J Am Soc Nephrol, 28, pp.2472~2481 (2017)
33. Liu X, "Tubule-derived exosomes play a central role in fibroblast activation and kidney fibrosis", Kidney Int, 97, pp.1181~1195 (2020)
34. Borges FT, "Extracellular vesicles : structure, function, and potential clinical uses in renal diseases", Braz J Med Biol Res, 46, pp.824~830 (2013)
35. Jiang XC, "Exosomes as novel bio-carriers for gene and drug delivery", Int J Pharm, 521, pp.167~175 (2017)
36. Mitsuo Kato, "Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease", Kidney Research and Clinical Practice, 37(3), pp.197~209 (2018), 대한신장학회
37. Tang TT, "Employing macrophage-derived microvesicle for kidney-targeted delivery of dexamethasone : an efficient therapeutic strategy against renal inflammation and fibrosis", Theranostics, 9, pp.4740~4755 (2019)
38. Yim N, "Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module", Nat Commun, 7, pp.12277~ (2016)
39. Choi H, "Exosome-based delivery of super-repressor IκBα relieves sepsis-associated organ damage and mortality", Sci Adv, 6, pp.eaaz6980~ (2020)
40. Kim S, "Exosome-based delivery of super-repressor IκBα ameliorates kidney ischemiareperfusion injury", Kidney Int, 100, pp.570~584 (2021)
41. Wang B, "Mesenchymal stem cells deliver exogenous microRNA-let7c via exosomes to attenuate renal fibrosis", Mol Ther, 24, pp.1290~1301 (2016)
42. Zhang A, "Exogenous miR-26a suppresses muscle wasting and renal fibrosis in obstructive kidney disease", FASEB J, 33, pp.13590~13601 (2019)
43. Wang H, "Exosome-mediated miR-29 transfer reduces muscle atrophy and kidney fibrosis in mice", Mol Ther, 27, pp.571~583 (2019)
44. Gu D, "Mesenchymal stromal cells derived extracellular vesicles ameliorate acute renal ischemia reperfusion injury by inhibition of mitochondrial fission through miR-30", Stem Cells Int, 2016, pp.2093940~ (2016)
45. Ju GQ, "Microvesicles derived from human umbilical cord mesenchymal stem cells facilitate tubular epithelial cell dedifferentiation and growth via hepatocyte growth factor induction", PLoS One, 10, pp.e0121534~ (2015)
46. Du T, "Microvesicles derived from human umbilical cord mesenchymal stem cells ameliorate renal ischemia-reperfusion injury via delivery of miR-21", Cell Cycle, 19, pp.1285~1297 (2020)
47. Collino F, "Adipose-derived mesenchymal stromal cells under hypoxia : changes in extracellular vesicles secretion and improvement of renal recovery after ischemic injury", Cell Physiol Biochem, 52, pp.1463~1483 (2019)
48. Xiang E, "Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis", Stem Cell Res Ther, 11, pp.336~ (2020)
49. Grange C, "Stem cellderived extracellular vesicles inhibit and revert fibrosis progression in a mouse model of diabetic nephropathy", Sci Rep, 9, pp.4468~ (2019)
50. Wael Nassar, "Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases", 생체재료학회지, 20(3), pp.200~210 (2016), 한국생체재료학회[DOI]
51. Jin J, "Mesenchymal stem cells attenuate renal fibrosis via exosomes-mediated delivery of microRNA Let-7i-5p antagomir", Int J Nanomedicine, 16, pp.3565~3578 (2021)
52. Du T, "Microvesicles derived from human umbilical cord mesenchyme promote M2 macrophage polarization and ameliorate renal fibrosis following partial nephrectomy via hepatocyte growth factor", Hum Cell, 34, pp.1103~1113 (2021)
53. Chen L, "Exosomes derived from GDNF-modified human adipose mesenchymal stem cells ameliorate peritubular capillary loss in tubulointerstitial fibrosis by activating the SIRT1", eNOS signaling pathway, 2020, pp.10, 9425~9442

관련 논문AI추천